Skip to main content

Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001012477

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

13F holders, Q4 2024

Institutional positions in Avadel Pharmaceuticals PLC as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
160
−15 vs. Q3 2024
Shares held
79.7M
+5.03M (+6.7%) vs. Q3 2024
Total value
$837.4M
−$141.5M (−14.5%) vs. Q3 2024
New holders
25
69 more added
Sold out
40
39 more reduced

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AVDL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 160 institutions
Q1 2021: 77 institutionsQ2 2021: 80 institutionsQ3 2021: 82 institutionsQ4 2021: 85 institutionsQ1 2022: 81 institutionsQ2 2022: 82 institutionsQ3 2022: 76 institutionsQ4 2022: 83 institutionsQ1 2023: 93 institutionsQ2 2023: 101 institutionsQ3 2023: 99 institutionsQ4 2023: 113 institutionsQ1 2024: 126 institutionsQ2 2024: 156 institutionsQ3 2024: 176 institutionsQ4 2024: 160 institutionsQ1 2025: 177 institutionsQ2 2025: 174 institutionsQ3 2025: 188 institutionsQ4 2025: 208 institutionsQ1 2026: 2 institutionsQ2 2026: 1 institution
Value heldQ4 2024: $837.4M
Q1 2021: $294.4MQ2 2021: $219.1MQ3 2021: $314.2MQ4 2021: $287.0MQ1 2022: $244.5MQ2 2022: $82.3MQ3 2022: $157.2MQ4 2022: $239.5MQ1 2023: $443.2MQ2 2023: $856.2MQ3 2023: $559.4MQ4 2023: $795.3MQ1 2024: $1.18BQ2 2024: $1.04BQ3 2024: $979.2MQ4 2024: $837.4MQ1 2025: $613.0MQ2 2025: $721.2MQ3 2025: $1.22BQ4 2025: $1.60BQ1 2026: $442Q2 2026: $16
Institutions holding AVDL and their total value by quarter
QuarterHoldersValue
Q2 20261$16
Q1 20262$442
Q4 2025208$1.60B
Q3 2025188$1.22B
Q2 2025174$721.2M
Q1 2025177$613.0M
Q4 2024160$837.4M
Q3 2024176$979.2M
Q2 2024156$1.04B
Q1 2024126$1.18B
Q4 2023113$795.3M
Q3 202399$559.4M
Q2 2023101$856.2M
Q1 202393$443.2M
Q4 202283$239.5M
Q3 202276$157.2M
Q2 202282$82.3M
Q1 202281$244.5M
Q4 202185$287.0M
Q3 202182$314.2M
Q2 202180$219.1M
Q1 202177$294.4M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Avadel Pharmaceuticals PLC; share changes are against Q3 2024.

Institutions holding AVDL in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Carmichael Hill & Associates, Inc.––––Not filed